Edgewise Therapeutics Files 8-K on Financials
Ticker: EWTX · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1710072
| Field | Detail |
|---|---|
| Company | Edgewise Therapeutics, Inc. (EWTX) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: EDGW
TL;DR
Edgewise Therapeutics (EDGW) filed an 8-K on March 3rd detailing financial results and operations.
AI Summary
Edgewise Therapeutics, Inc. filed an 8-K on March 3, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 1715 38th St., Boulder, CO 80301.
Why It Matters
This filing provides crucial updates on Edgewise Therapeutics' financial health and operational status, which is important for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial results and does not indicate any immediate or significant risks.
Key Players & Entities
- Edgewise Therapeutics, Inc. (company) — Registrant
- March 3, 2025 (date) — Date of earliest event reported
- 1715 38th St., Boulder, CO 80301 (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Edgewise Therapeutics, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 3, 2025.
Where are Edgewise Therapeutics, Inc.'s principal executive offices located?
Edgewise Therapeutics, Inc.'s principal executive offices are located at 1715 38th St., Boulder, CO 80301.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 82-1725586.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Edgewise Therapeutics, Inc. (EWTX).